Last Updated on May 17, 2024 by The Health Master
PCI Approval
In a major relief for pharmacy institutions across India, the Pharmacy Council of India (PCI) has extended the deadline for the PCI approval process for the academic year 2024-25.
This extension comes after a Supreme Court order issued in April 2024, granting the PCI’s request for more time.
Extended Deadlines for PCI Approval and Appeal
- PCI Approval Process Extended: Institutions now have until October 10th, 2024, to complete the application process for PCI approval to conduct pharmacy courses in the 2024-25 academic year.
- Appeal Process Extended: The deadline for appeals and submitting compliance documents has also been extended to November 30th, 2024.
Background: Stakeholders’ Requests and Legal Challenges
- Earlier Extension: In January 2024, the PCI had already extended the timeline for application submission on its online portal after receiving requests from stakeholders.
- Legal Challenge: It’s important to note that several pharmacy institutions had challenged the PCI approval process in the Delhi High Court.
What Courses Are Included in the PCI Approval Process?
The PCI approval process applies to various pharmacy programs, including:
- Diploma in Pharmacy (D.Pharm)
- Bachelor of Pharmacy (B.Pharm)
- Master of Pharmacy (M.Pharm)
- Doctor of Pharmacy (Pharm.D)
- Doctor of Pharmacy (Post Baccalaureate) (Pharm.D (Post Baccalaureate))
- Bachelor of Pharmacy (Practice)
What Documents Are Required for New Course Introduction?
Institutions seeking to introduce new pharmacy courses for the 2024-25 academic year must submit the following documents along with their application:
- Required Fees: Pharmacy Education Regulatory Charges (PERC) (non-refundable) with Goods and Services Tax (GST)
- Mandatory Documents:
- For B.Pharm: Consent of affiliation from the examination authority and No Objection Certificate (NOC) from the State Government (or government communication if NOC issuance is discontinued)
- For D.Pharm, Pharm.D programs (both regular and Post Baccalaureate), new M.Pharm courses, new M.Pharm specializations, and B.Pharm (Practice):
- Consent of affiliation from the examining authority
- Copy of a Memorandum of Understanding (MoU) with a 300-bed hospital (applicable for Pharm.D programs only)
Requirements for Existing Institutions
- Mandatory Application: All institutions currently approved by the PCI must re-apply through the PCI portal and submit all necessary information and documents.
- Retention of Existing PCI Approval: Institutions with PCI approval valid for the 2024-25 academic year or beyond must still apply through the Standard Information Format and pay the mandatory PERC to retain their existing PCI approval.
Faculty Registration Update
All faculty members must register again on the PCI’s new portal under the pharmacist module and submit a pharmacist profile.
Technical Support
Institutions facing technical difficulties during the application process can upload their queries on the PCI website’s grievance portal.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
How to become a skilled Pharmacist
Pharmacists can play a vital role in Enhancing Healthcare in India
Pharmacists deserve more recognition for their work
Crucial role of pharmacists in health care
Pharmacists – The Doctors behind the screens
World Pharmacists Day: Salute to all Pharmacists – The Backbone of Health system
PCI to conduct GPAT exams on June 8
PCI extends last date for approval process for Pharmacy Colleges
Anil Mittal promoted as Registrar cum Secretary at the PCI
PCI: Pharmacy is an independent profession, not paramedical course
PCI and IPA join hands to enhance quality of Pharmacy Education
PCI to introduce Pharmacy Practical Training for D Pharm student
USFDA approval granted for these 5 products: Alembic
Fake Reference Material Certificates Threaten Integrity: How to Ensure Authenticity
USFDA issued Form 483 with 1 observation to Cipla
Noida Drug Dept. Cracks Down on Unregulated Medicines
USFDA approval granted for this Fertility Drug
USFDA issues warning letter to Global Cosmetics Company Limited
USFDA Inspection with Positive EIR to Alembic Pharma
USFDA Approval granted for Generic Travoprost Eye Drops
India’s Fight to Reduce Reliance on China for Bulk Drug
Limit of Paracetamol (Acetamenophen) in Fixed Dose Combinations
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: